Donor age greater than 50 years does not influence midterm results of heart transplantation

Transplantation Proceedings

Volumn 28, Issue 1, 1996, Pages 91-92

  Livi, U ^a   Caforio, A L P ^a   Tursi, V ^a   Boffa, G M ^a   Borrelli, M R ^a   Bauce, B ^a   Thiene, G ^a   Casarotto, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CATECHOLAMINE; CYCLOSPORIN;

ADULT; AGE; AGED; ARTIFICIAL HEART PACEMAKER; ASSISTED VENTILATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CORONARY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; VENTRICULAR FUNCTION, LEFT;

EID: 0029923391     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)